Stuart Jon Spechler

Stuart Jon Spechler's AcademicInfluence.com Rankings

Stuart Jon Spechler

Physics

#3706

World Rank

#5211

Historical Rank

physics Degrees

Download Badge

Physics

Stuart Jon Spechler's Degrees

Bachelors Physics University of California, Berkeley
PhD Physics Stanford University

Why Is Stuart Jon Spechler Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Stuart Jon Spechler's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification (1999) (2034)
Eosinophilic esophagitis: updated consensus recommendations for children and adults. (2011) (1878)
Radiofrequency ablation in Barrett's esophagus with dysplasia. (2009) (1013)
The endoscopic assessment of esophagitis: a progress report on observer agreement. (1996) (997)
American Gastroenterological Association medical position statement on the management of Barrett's esophagus. (2011) (943)
American Gastroenterological Association technical review on the management of Barrett's esophagus. (2011) (926)
Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. (2001) (888)
Clinical practice. Barrett's Esophagus. (2002) (673)
Classification of oesophageal motility abnormalities (2001) (609)
Prevalence of metaplasia at the gastro-oesophageal junction (1994) (577)
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference. (2018) (561)
A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. (2004) (556)
Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. (1992) (535)
The columnar-lined esophagus, intestinal metaplasia, and Norman Barrett. (1996) (495)
Adenocarcinoma and Barrett's esophagus. An overrated risk? (1984) (464)
Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. (2011) (446)
Epidemiology and natural history of gastro-oesophageal reflux disease. (1992) (417)
Nighttime heartburn is an under-appreciated clinical problem that impacts sleep and daytime function: the results of a Gallup survey conducted on behalf of the American Gastroenterological Association (2003) (394)
Early diagnosis of pancreatic infection by computed tomography-guided aspiration. (1987) (385)
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. (2012) (383)
Thoughts on the Complex Relationship Between Gastroesophageal Reflux Disease and Eosinophilic Esophagitis (2007) (348)
Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. (2009) (330)
Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. (2000) (306)
Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD (2012) (287)
Potential Anti-inflammatory Effects of Proton Pump Inhibitors: A Review and Discussion of the Clinical Implications (2009) (284)
Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis (2015) (265)
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer (2009) (264)
Barrett esophagus and risk of esophageal cancer: a clinical review. (2013) (255)
Barrett's esophagus. (1994) (235)
The Risk of Lymph-Node Metastases in Patients With High-Grade Dysplasia or Intramucosal Carcinoma in Barrett's Esophagus: A Systematic Review (2012) (220)
Omeprazole Blocks STAT6 Binding to the Eotaxin-3 Promoter in Eosinophilic Esophagitis Cells (2012) (215)
Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus. (2002) (209)
AGA technical review on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. (1999) (200)
Acid, bile, and CDX: the ABCs of making Barrett's metaplasia. (2008) (198)
History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus. (2010) (194)
The prevalence of Barrett's esophagus in the US: estimates from a simulation model confirmed by SEER data. (2010) (193)
The increasing frequency of adenocarcinoma of the esophagus (1989) (193)
Buried Metaplasia After Endoscopic Ablation of Barrett's Esophagus: A Systematic Review (2011) (181)
Duration of the interval between the completion of bowel preparation and the start of colonoscopy predicts bowel-preparation quality. (2009) (181)
The role of gastric carditis in metaplasia and neoplasia at the gastroesophageal junction. (1999) (168)
Bone marrow progenitor cells contribute to esophageal regeneration and metaplasia in a rat model of Barrett's esophagus. (2008) (166)
Role of nitric oxide in esophageal peristalsis in the opossum. (1992) (162)
Hallmarks of cancer progression in Barrett's oesophagus (2002) (161)
Immortalized epithelial cells derived from human colon biopsies express stem cell markers and differentiate in vitro. (2010) (160)
Intestinal Differentiation in Metaplastic, Nongoblet Columnar Epithelium in the Esophagus (2009) (154)
Diagnostic inconsistencies in Barrett's esophagus (1994) (151)
Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes. (2016) (151)
Phenotype of Barrett's Esophagus and Intestinal Metaplasia of the Distal Esophagus and Gastroesophageal Junction: An Immunohistochemical Study of Cytokeratins 7 and 20, Das-1 and 45MI (2001) (150)
Systematic review: the role of bile acids in the pathogenesis of gastro‐oesophageal reflux disease and related neoplasia (2011) (143)
Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn. (2019) (131)
Barrett's esophagus (1988) (126)
ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. (2021) (126)
Deoxycholic acid causes DNA damage while inducing apoptotic resistance through NF-κB activation in benign Barrett's epithelial cells. (2011) (123)
Dysplasia in Barrett's Esophagus: Limitations of Current Management Strategies (2005) (116)
Esophagitis Dissecans Superficialis (“Sloughing esophagitis”): A Clinicopathologic Study of 12 Cases (2009) (111)
Sorafenib for Treatment of Hepatocellular Carcinoma: A Systematic Review (2012) (110)
Heartburn in patients with achalasia. (1995) (109)
Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma (2009) (109)
American gastroenterological association medical position statement on treatment of patients with dysphagia caused by benign disorders of the distal esophagus. (1999) (103)
Might the Use of Acid-Suppressive Medications Predispose to the Development of Eosinophilic Esophagitis? (2009) (102)
Tissue remodeling in eosinophilic esophagitis. (2012) (102)
Acid and bile salt-induced CDX2 expression differs in esophageal squamous cells from patients with and without Barrett's esophagus. (2010) (100)
A Systematic Review of the Risk of Perforation During Esophageal Dilation for Patients with Eosinophilic Esophagitis (2010) (97)
An Implantable, Batteryless, and Wireless Capsule With Integrated Impedance and pH Sensors for Gastroesophageal Reflux Monitoring (2012) (96)
Intestinal metaplasia at the gastroesophageal junction. (2004) (96)
In benign Barrett's epithelial cells, acid exposure generates reactive oxygen species that cause DNA double-strand breaks. (2009) (95)
Concepts in the Prevention of Adenocarcinoma of the Distal Esophagus and Proximal Stomach (2005) (91)
Characterization of telomerase-immortalized, non-neoplastic, human Barrett's cell line (BAR-T). (2007) (90)
Pathogenesis and Cells of Origin of Barrett's Esophagus. (2019) (88)
Percutaneous drainage of infected pancreatic pseudocysts. (1984) (86)
Diagnosis of Esophageal Motility Disorders: Esophageal Pressure Topography vs. Conventional Line Tracing (2015) (86)
Elevated HbA1c Is an Independent Predictor of Aggressive Clinical Behavior in Patients with Colorectal Cancer: A Case-Control Study (2008) (86)
Endoscopic surveillance for patients with Barrett esophagus: does the cancer risk justify the practice? (1987) (85)
Current strategies in the management of intra-abdominal abscesses in Crohn's disease. (2011) (85)
Familial Barrett esophagus and adenocarcinoma of the gastroesophageal junction. (1993) (83)
Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium. (2015) (82)
Fundoplication and the Risk of Esophageal Cancer in Gastroesophageal Reflux Disease: A Veterans Affairs Cohort Study (2005) (81)
Hedgehog signaling regulates FOXA2 in esophageal embryogenesis and Barrett's metaplasia. (2014) (80)
Barrett's esophagus : pathophysiology, diagnosis, and management (1985) (79)
Gastroesophageal reflux disease versus Helicobacter pylori infection as the cause of gastric carditis. (1998) (78)
Esophageal adenocarcinoma arising in Barrett esophagus. (2009) (75)
The columnar-lined esophagus. History, terminology, and clinical issues. (1997) (75)
Bile salt exposure increases proliferation through p38 and ERK MAPK pathways in a non-neoplastic Barrett's cell line. (2006) (74)
Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. (2004) (73)
NADPH Oxidase NOX5-S Mediates Acid-induced Cyclooxygenase-2 Expression via Activation of NF-κBin Barrett's Esophageal Adenocarcinoma Cells* (2007) (72)
Barrett's esophagus and esophageal adenocarcinoma: pathogenesis, diagnosis, and therapy. (2002) (70)
Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells. (2011) (68)
In oesophageal squamous cells exposed to acidic bile salt medium, omeprazole inhibits IL-8 expression through effects on nuclear factor-κB and activator protein-1 (2013) (68)
Barrett's esophagus: an overrated cancer risk factor. (2000) (67)
Prevalence and significance of pancreatic acinar metaplasia at the gastroesophageal junction. (1996) (66)
Management Options for Patients With GERD and Persistent Symptoms on Proton Pump Inhibitors: Recommendations From an Expert Panel (2018) (65)
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. (1999) (64)
Surgical Bypass Versus Endoscopic Stenting for Malignant Gastroduodenal Obstruction: A Decision Analysis (2006) (63)
Detection by scanning electron microscopy of a distinctive esophageal surface cell at the junction of squamous and Barrett's epithelium (2005) (63)
Characterisation of telomerase immortalised normal human oesophageal squamous cells (2003) (62)
Significance of acid-mucin-positive nongoblet columnar cells in the distal esophagus and gastroesophageal junction. (1999) (62)
Use of proton pump inhibitors and subsequent risk of celiac disease. (2014) (59)
Gastric and Esophageal pH in Patients With Barrett's Esophagus Treated With Three Esomeprazole Dosages: A Randomized, Double-Blind, Crossover Trial (2006) (58)
The role of cricopharyngeus muscle in pharyngoesophageal disorders (2005) (57)
Efficacy of Prophylactic Hemoclips in Prevention of Delayed Post-Polypectomy Bleeding in Patients with Large Colonic Polyps. (2019) (57)
Short and ultrashort Barrett's esophagus--what does it mean? (1997) (56)
Scanning electron microscopy of Barrett's epithelium and its correlation with light microscopy and mucin stains. (1986) (56)
Acid Has Antiproliferative Effects in Nonneoplastic Barrett's Epithelial Cells (2007) (56)
JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE (2016) (55)
213 A Randomized, Multicenter, Sham-Controlled Trial of Radiofrequency Ablation (RFA) for Subjects with Barrett's Esophagus (Be) Containing Dysplasia: Interim Results of the Aim Dysplasia Trial (2008) (55)
Mechanisms of oxidant production in esophageal squamous cell and Barrett's cell lines. (2008) (53)
Acid-induced p16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX5-S. (2010) (53)
In Barrett's esophagus patients and Barrett's cell lines, ursodeoxycholic acid increases antioxidant expression and prevents DNA damage by bile acids. (2014) (53)
Multilayered Epithelium in Mucosal Biopsy Specimens From the Gastroesophageal Junction Region is a Histologic Marker of Gastroesophageal Reflux Disease (2009) (52)
Autocrine VEGF signaling promotes proliferation of neoplastic Barrett's epithelial cells through a PLC-dependent pathway. (2014) (52)
Low rate of postpolypectomy bleeding among patients who continue thienopyridine therapy during colonoscopy. (2013) (51)
The Management of Patients Who Have “Failed” Antireflux Surgery (2004) (51)
Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group. (1994) (50)
The Prophylactic Placement of Hemoclips to Prevent Delayed Post-polypectomy Bleeding: An Unnecessary Practice? A Case Control Study (2014) (50)
For Patients with Colorectal Cancer, the Long-Term Use of Statins Is Associated with Better Clinical Outcomes (2009) (48)
GERD 2003 – A Consensus on the Way Ahead (2003) (47)
Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-kappaB pathway. (2009) (47)
Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett’s Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett’s Esophagus) Consortium (2017) (46)
Can Eosinophilic Esophagitis Cause Achalasia and Other Esophageal Motility Disorders? (2018) (46)
Re-examination of the Cost-Effectiveness of Surgical Versus Medical Therapy in Patients With Gastroesophageal Reflux Disease: The Value of Long-Term Data Collection (2004) (46)
High-Frequency Probe Ultrasonography Has Limited Accuracy for Detecting Invasive Adenocarcinoma in Patients with Barrett's Esophagus and High-Grade Dysplasia or Intramucosal Carcinoma: A Case Series (2006) (45)
Cardiac epithelium is found infrequently in the gastric cardia (1998) (45)
The Rate of Post-Polypectomy Bleeding for Patients on Uninterrupted Clopidogrel Therapy During Elective Colonoscopy Is Acceptably Low (2011) (45)
Review article: oesophageal complications and consequences of persistent gastro‐oesophageal reflux disease (2004) (44)
Eosinophilic esophagitis: interactions with gastroesophageal reflux disease. (2014) (43)
Acid increases MAPK-mediated proliferation in Barrett's esophageal adenocarcinoma cells via intracellular acidification through a Cl-/HCO3- exchanger. (2005) (43)
Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells. (2019) (42)
Proton Pump Inhibitors Decrease Eotaxin-3 Expression in the Proximal Esophagus of Children with Esophageal Eosinophilia (2014) (42)
NOD-Like Receptor Protein 3 Inflammasome Priming and Activation in Barrett’s Epithelial Cells (2016) (42)
Prevalence of normal serum amylase levels in patients with acute alcoholic pancreatitis (1983) (41)
A Comparison of the Rate of Gastrointestinal Bleeding in Patients Taking Non-Vitamin K Antagonist Oral Anticoagulants or Warfarin (2017) (40)
The Impact of Obesity on the Rise in Esophageal Adenocarcinoma Incidence: Estimates from a Disease Simulation Model (2011) (40)
Differences in activity and phosphorylation of MAPK enzymes in esophageal squamous cells of GERD patients with and without Barrett's esophagus. (2008) (39)
Development for and results of the use of a gastroesophageal reflux disease activity index as an outcome variable in a clinical trial. VA Cooperative Study Group on Gastroesophageal Reflux Disease (GERD). (1994) (39)
Differences in ERK Activation in Squamous Mucosa in Patients Who Have Gastroesophageal Reflux Disease with and without Barrett's Esophagus (2005) (38)
Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. (2016) (37)
Screening and surveillance for complications related to gastroesophageal reflux disease. (2001) (37)
The Natural History of Dysplasia and Cancer in Esophagitis and Barrett Esophagus (2003) (36)
Integrated approach to treatment of children and adults with eosinophilic esophagitis. (2008) (36)
Localization of calcitonin gene-related peptide in human esophageal Langerhans cells. (1991) (36)
Clinical Implications of Histologic Abnormalities in Ileocolonic Biopsies of Patients With Crohn’s Disease in Remission (2017) (35)
The columnar lined oesophagus: a riddle wrapped in a mystery inside an enigma (1997) (35)
Proliferative characteristics of intestinalized mucosa in the distal esophagus and gastroesophageal junction (short-segment Barrett's esophagus): a case control study. (1999) (35)
Aspirin prevents NF-κB activation and CDX2 expression stimulated by acid and bile salts in oesophageal squamous cells of patients with Barrett's oesophagus (2017) (35)
Barrett's epithelium complicating lye ingestion with sparing of the distal esophagus. (1981) (34)
A new paradigm for GERD pathogenesis. Not acid injury, but cytokine‐mediated inflammation driven by HIF‐2&agr;: a potential role for targeting HIF‐2&agr; to prevent and treat reflux esophagitis (2017) (34)
Barrett's esophagus: what's new and what to do. (1989) (34)
All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett's cells. (2007) (33)
Carcinogenesis at the gastroesophageal junction: free radicals at the frontier. (2002) (33)
The effects of antireflux therapy on pulmonary function in patients with severe gastroesophageal reflux disease. Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. (1995) (32)
New Screening Techniques in Barrett's Esophagus: Great Ideas or Great Practice? (2018) (32)
Aberrant p53 Immunostaining in Barrett’s Esophagus Predicts Neoplastic Progression: Systematic Review and Meta-Analyses (2019) (32)
Prone Positioning of Obese Patients for Colonoscopy Results in Shortened Cecal Intubation Times: A Randomized Trial (2013) (31)
Gastrointestinal tract bleeding of unknown origin. (1982) (31)
Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells. (2012) (31)
Fatal hyperammonemic encephalopathy after gastric bypass surgery. (2008) (30)
The Long-Term Use of Statins Is Associated with a Decreased Incidence of Adenomatous Colon Polyps (2009) (30)
Intestinal Metaplasia at the Gastroesophageal Junction: Barrett’s, Bacteria, and Biomarkers (2003) (30)
Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD (2016) (30)
Clinical manifestations and esophageal complications of GERD. (2003) (29)
The prevalence of Barrett's esophagus in patients with chronic peptic esophageal strictures (1983) (29)
Incidence of Colorectal Cancer and Extracolonic Cancers in Veteran Patients With Inflammatory Bowel Disease. (2018) (29)
Pneumatic dilation and laparoscopic Heller's myotomy equally effective for achalasia. (2011) (29)
Case-control study of factors that trigger inflammatory bowel disease flares. (2014) (29)
White Paper AGA: Drug Development for Eosinophilic Esophagitis (2017) (29)
Malignant Transformation of Non-Neoplastic Barrett's Epithelial Cells through Well-Defined Genetic Manipulations (2010) (29)
Consensus Statement for Management of Gastroesophageal Reflux Disease: result of workshop meeting at Yale University School of Medicine, Department of Surgery, November 16 and 17, 1997. (1998) (28)
Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality (2017) (28)
Barrett's metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reflux. (2017) (28)
Clinical Implications of Histologic Abnormalities in Colonic Biopsy Specimens from Patients with Ulcerative Colitis in Clinical Remission (2013) (28)
Management of Nondysplastic Barrett's Esophagus: Where Are We Now? (2009) (28)
Gastroesophageal reflux disease (1998) (28)
Lactic acidosis in oat cell carcinoma with extensive hepatic metastases. (1978) (28)
Obesity Is Associated with an Increased Prevalence of Advanced Adenomatous Colon Polyps in a Male Veteran Population (2009) (28)
The Role of Bile Acids in the Neoplastic Progression of Barrett’s Esophagus – A Short Representative Overview (2012) (28)
Batteryless implantable dual-sensor capsule for esophageal reflux monitoring. (2013) (27)
Value of cytology in detecting intestinal metaplasia and associated dysplasia at the gastroesophageal junction. (1997) (26)
In non-neoplastic Barrett's epithelial cells, acid exerts early antiproliferative effects through activation of the Chk2 pathway. (2007) (25)
Identification of Quality Measures for Performance of and Interpretation of Data From Esophageal Manometry. (2016) (25)
Barrett's esophagus: should we brush off this ballooning problem? (1997) (25)
Thermal Ablation of Barrett's Esophagus: A Heated Debate (2006) (24)
Clinical aspects of genetic variability in Helicobacter pylori. (2000) (24)
Cholestasis and toxic epidermal necrolysis associated with phenytoin sodium ingestion: the role of bile duct injury. (1981) (24)
Surgery for gastroesophageal reflux disease: esophageal impedance to progress? (2009) (24)
Managing Barrett's oesophagus (2003) (24)
Classifying Esophageal Motility by FLIP Panometry: A Study of 722 Subjects With Manometry (2021) (23)
Columnar-lined esophagus. Definitions. (2002) (23)
An implantable batteryless wireless impedance sensor for gastroesophageal reflux diagnosis (2010) (23)
Mitochondrial STAT3 contributes to transformation of Barrett's epithelial cells that express oncogenic Ras in a p53-independent fashion. (2015) (22)
Eosinophilic esophagitis: novel concepts regarding pathogenesis and clinical manifestations (2019) (22)
Screening and surveillance for Barrett's esophagus—an unresolved dilemma (2007) (21)
Esophageal columnar metaplasia (Barrett's esophagus). (1997) (21)
Laser photoablation of Barrett's epithelium: burning issues about burning tissues. (1993) (21)
Disputing dysplasia. (2001) (21)
In oesophageal squamous cells, nitric oxide causes S-nitrosylation of Akt and blocks SOX2 (sex determining region Y-box 2) expression (2015) (20)
Irreversible ototoxicity associated with difluoromethylornithine. (2004) (20)
Mucosal pathogenesis in gastro‐esophageal reflux disease (2020) (20)
New Eosinophilic Esophagitis Concepts Call for Change in Proton Pump Inhibitor Management Before Diagnostic Endoscopy. (2018) (20)
Wilson's disease: diagnostic difficulties in the patient with chronic hepatitis and hypoceruloplasminemia. (1980) (20)
Barrett's oesophagus: diagnosis and management. (2000) (20)
Barrett's esophagus: is the goblet half empty? (2012) (19)
Barrett's esophagus. (1986) (19)
A System to Assess the Competency for Interpretation of Esophageal Manometry Identifies Variation in Learning Curves (2017) (19)
Development, Calibration, and Validation of a U.S. White Male Population-Based Simulation Model of Esophageal Adenocarcinoma (2010) (19)
Does Barrett's Esophagus Regress after Surgery (or Proton Pump Inhibitors) (2014) (19)
Development and Characterization of a Surgical Mouse Model of Reflux Esophagitis and Barrett's Esophagus (2014) (18)
Obtaining adequate lamina propria for subepithelial fibrosis evaluation in pediatric eosinophilic esophagitis. (2018) (18)
Radiofrequency Ablation of Barrett's Esophagus Reduces Esophageal Adenocarcinoma Incidence and Mortality in a Comparative Modeling Analysis (2017) (18)
The Effect of Proton Pump Inhibitors on Barrett's Esophagus. (2015) (18)
International consensus recommendations for eosinophilic gastrointestinal disease nomenclature. (2022) (17)
The reticular pattern as a radiographic sign of the Barrett esophagus: an assessment. (1984) (17)
Proton Pump Inhibitors: What the Internist Needs to Know. (2019) (17)
877 In Esophageal Squamous Epithelial Cell Lines From Patients With Eosinophilic Esophagitis (EoE), Omeprazole Blocks the Stimulated Secretion of Eotaxin-3: A Potential Anti-Inflammatory Effect of Omeprazole in EoE That is Independent of Acid Inhibition. (2010) (16)
A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association: Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance. (2017) (16)
Evaluation and management of patients with recurrent peptic ulcer disease after acid-reducing operations: A systematic review (2003) (16)
Esophageal human β-defensin expression in eosinophilic esophagitis (2013) (16)
2014 SSAT State-of-the-Art Conference: Advances in Diagnosis and Management of Gastroesophageal Reflux Disease (2014) (16)
In Esophageal Squamous Cells from Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion through Effects on Intracellular Calcium and a Non-Gastric Proton Pump. (2021) (16)
Screening and surveillance for Barrett’s esophagus (2007) (16)
GERD and its complications. (2000) (15)
Critical review of the diagnosis of columnar metaplasia in the esophagus and the esophagogastric junction: the Paris workshop (2005) (15)
Esophageal complications of gastroesophageal reflux disease: presentation, diagnosis, management, and outcomes. (2003) (15)
Barrett’s esophagus: A molecular perspective (2005) (14)
Nighttime heartburn is an underappreciated clinical problem that impacts sleep and daytime function (2001) (14)
Stem cells in Barrett's esophagus: HALOs or horns? (2008) (14)
Mucosal peptidergic innervation of the opossum esophagus and anal canal: a comparison with snout skin. (1990) (14)
Banding Without Resection (Endoscopic Mucosal Ligation) as a Novel Approach for the Ablation of Short-Segment Barrett's Epithelium: Results of a Pilot Study (2007) (14)
Speculation as to why the Frequency of Eosinophilic Esophagitis Is Increasing (2018) (14)
Cancer surveillance in Barrett's esophagus: what is the end point? (1994) (14)
Reduction in Low-Density Lipoprotein Cholesterol Levels During Statin Therapy Is Associated With a Reduced Incidence of Advanced Colon Polyps (2009) (14)
Cardiac Metaplasia: Follow, Treat, or Ignore? (2018) (13)
Barrett's esophagus: chemoprevention. (2003) (12)
Refractory Gastroesophageal Reflux Disease and Functional Heartburn. (2020) (12)
Endoscopic therapy in Barrett's esophagus: when and how? (2009) (12)
Columnar-Lined Esophagus Develops via Wound Repair in a Surgical Model of Reflux Esophagitis (2018) (12)
Gain of allelic gene expression for IGF-II occurs frequently in Barrett's esophagus. (2006) (11)
Barrett's Esophagus: The American Perspective (2013) (11)
GERD Evaluation: Time for a New Paradigm? (2007) (11)
Barrett’s Esophagus Without Dysplasia: Wait or Ablate? (2011) (11)
Strategies of Cancer Prevention in Gastroenterology (2009) (11)
Development of an Implanted RFID Impedance Sensor for Detecting Gastroesophageal Reflux (2007) (11)
Lower esophageal sphincter muscle of patients with achalasia exhibits profound mast cell degranulation (2020) (11)
How much can we know about acute pancreatitis? (1985) (10)
Controversies in Barrett esophagus. (2014) (10)
Medical or invasive therapy for GERD: an acidulous analysis. (2003) (10)
Evaluation and Treatment of Patients with Persistent Reflux Symptoms Despite Proton Pump Inhibitor Treatment. (2020) (10)
Laryngopharyngeal reflux: a cause of faulty phonation or a faulted, phony diagnosis? (2006) (10)
A Balancing View: To Screen or Not to Screen: Scoping Out the Issues (2004) (10)
Kyoto international consensus report on anatomy, pathophysiology and clinical significance of the gastro-oesophageal junction (2022) (10)
Are we underestimating acid reflux? (2004) (10)
Barrett's esophagus: Clinical issues. (2011) (10)
GERD is associated with shortened telomeres in the squamous epithelium of the distal esophagus. (2007) (10)
Upper gastrointestinal bleeding in a patient with AIDS (2006) (9)
The Durability of Antireflux Surgery. (2017) (9)
Use of Hemoclips and Other Measures to Prevent Bleeding During Colonoscopy by Gastroenterologists in Veterans Affairs Hospitals (2014) (9)
A 59-year-old woman with gastroesophageal reflux disease and Barrett esophagus. (2003) (9)
Selective inhibition of cyclooxygenase-2 inhibits growth and induces apoptosis in human esophageal adenocarcinoma cells (2000) (9)
Remote detection of gastroesophageal reflux using an impedance and pH sensing transponder (2012) (9)
Barrett's esophagus (1993) (9)
Endoscopic Assessment of Premalignant Esophageal Disorders (1992) (9)
Mast Cell Effects on Esophageal Smooth Muscle and their Potential Role in Eosinophilic Esophagitis and Achalasia. (2020) (9)
Obesity and Its Effects on the Esophageal Mucosal Barrier. (2021) (8)
Frequency of intestinal metaplasia at different sites in the esophagus and stomach (1998) (8)
Biologic Agent Use Varies Inversely with Age at Diagnosis in Crohn’s Disease (2010) (8)
Effects of non-steroidal anti-inflammatory drugs (NSAIDs) on acid reflux in patients with gastroesophageal reflux disease (GERD) (2000) (7)
Buried (but not dead) Barrett's metaplasia: tales from the crypts. (2012) (7)
M1030 Impact of Barrett's Esophagus Containing Dysplasia On Patient Quality of Life: Interim Results of a Randomized, Sham-Controlled Trial of Radiofrequency Ablation (AIM Dysplasia Trial) (2008) (7)
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 43-1985. A 70-year-old man with diarrhea, weight loss, and recurrent atrial fibrillation. (1985) (6)
Esophageal obstruction due to extensive intramural esophageal dissection: diagnosis and treatment using an endoscopic 'rendezvous' technique. (2007) (6)
Cardiac mucosa: the heart of the problem (2015) (6)
Gastroesophageal Reflux Disease and Eosinophilic Esophagitis. (2019) (6)
Mast cell numbers in the esophagus are increased in association with specialized intestinal metaplasia (1995) (6)
A 24-year-old man with asthma and bouts of epigastric pain, nausea, and vomiting (1992) (5)
Unique Clinical Features of Los Angeles Grade D Esophagitis Suggest That Factors Other Than Gastroesophageal Reflux Contribute to its Pathogenesis (2017) (5)
Su1333 The Prophylactic Placement of Hemoclips to Prevent Delayed Post Polypectomy Bleeding: An Unnecessary Practice? (2012) (5)
Barrett esophagus: a sequela of chemotherapy. (1991) (5)
Screening for Barrett's esophagus. (2002) (5)
In Barrett's Epithelial Cells, Weakly Acidic Bile Salt Solutions Cause Oxidative DNA Damage with Response and Repair Mediated by p38. (2020) (5)
STAT 3 contributes to transformation of Barrett ’ s epithelial cells that express oncogenic Ras in a p 53-independent fashion (2015) (5)
Serum amylase in pancreatitis (2005) (5)
Long-term outcome of medical and surgical therapies for GERD: Effects on GERD symptoms and signs (2000) (5)
Of Mice and Men and Metaplasia (2017) (5)
Does Helicobacter pylori infection contribute to gastroesophageal reflux disease? (1998) (5)
Esophageal Squamous Cell Lines Derived From GERD Patients With and Without Barrett's Esophagus Differ Markedly in Their Expression of SOX9 and Columnar Cytokeratins 8 and 18 (2011) (4)
Mechanisms and pathophysiology of Barrett oesophagus (2022) (4)
The relationship between esophageal acid exposure, dysplasia and extent of columnar metaplasia in Barrett's esophagus (2000) (4)
474 An Implantable, Wireless and Batteryless Impedance Sensor Capsule for Detecting Acidic and Non-Acidic Reflux (2008) (4)
Adenocarcinoma in Barrett's esophagus. (1987) (4)
Predictors of Early Mortality in Veteran Patients With Pancreatic Cancer: 21 (2015) (4)
Acid-induced p 16 hypermethylation contributes to development of esophageal adenocarcinoma via activation of NADPH oxidase NOX 5S (2010) (4)
W1080 An Implantable, Batteryless and Wireless Capsule with Integrated Impedance and pH Sensors for Detecting the Reflux of Acidic and Non-Acidic Materials (2009) (3)
Can reflux prevention prevent esophageal adenocarcinoma? (2002) (3)
Endoscopic Surveillance of Barrett’s Esophagus (1997) (3)
Biomarkers and photodynamic therapy for Barrett's esophagus: time to FISH or cut bait? (2008) (3)
Intragastric Acid Control in Patients Who Have Barrettʼs Esophagus: Comparison of Once- and Twice-Daily Regimens of Esomeprazole and Lansoprazole: 62 (2007) (3)
Information Assimilation and Distribution Challenges and Goals for Real and Virtual Journals (2005) (3)
408 TH2 Cytokines Stimulate Eotaxin-3 Secretion by Esophageal Fibroblasts: An Effect That Is Not Blocked by Omeprazole. (2013) (3)
202 Omeprazole and Fluticasone Inhibit IL-13-Stimulated Eotaxin-3 Expression by Esophageal Epithelial Cells Through Different Mechanisms and With Additive Effects: Rationale for Combining PPIs With Topical Steroids for EoE Patients (2015) (3)
896 Acid Induces DNA Double Strand Breaks Via Reactive Oxygen Species in Benign Barrett's Epithelial Cells (2008) (3)
Is their prevalence in patients with Barrett’s esophagus overestimated? (1989) (3)
Advances in Biomarkers for Risk Stratification in Barrett's Esophagus. (2021) (3)
A wireless sensor for detecting gastroesophageal reflux (2006) (3)
Clinical role of ambulatory reflux monitoring in PPI non‐responders: recommendation statements (2022) (3)
and Barrett's Esophagus (1984) (3)
Long-term outcome of medical andsurgical therapies for gerd: Effects on survival (2000) (3)
Mo1846 Clinical, Endoscopic and Histological Features of Patients With Lymphocytic Esophagitis Compared to Patients With GERD (2014) (3)
An Endoscopic and Histologic Study on Healing of Radiofrequency Ablation Wounds in Patients With Barrett's Esophagus (2022) (3)
615 - A VA Cooperative, Randomized Trial of Medical and Surgical Treatments for Patients with Heartburn that is Refractory to Proton Pump Inhibitors (2018) (3)
Screening for Barrett’s oesophagus: are we looking for the right thing? (2020) (3)
Risk of community-acquired pneumonia after acid-suppressive drugs (2005) (3)
Can therapy and surveillance prevent cancer of the esophagus (2003) (2)
EFFECT OF ESOMEPRAZOLE ON INTRAESOPHAGEAL pH IN PATIENTS WITH BARRETTʼS ESOPHAGUS: 46 (2004) (2)
Acid induces mitogen-activated protein kinase (MAPK) activation and decreases apoptosis in human esophageal adenocarcinoma cells (2001) (2)
Differences in Eotaxin-3 Expression After Stimulation With IL-13 and IL-4 in Esophageal Squamous Cell Lines From Patients With Eosinophilic Esophagitis and GERD. (2011) (2)
VEGF Signaling Exerts Pronounced Effects on Cell Growth in Transformed Barrett's Epithelial Cells. (2011) (2)
1039 How Durable Is the Reversion to Neosquamous Epithelium in Subjects Undergoing Radiofrequency Ablation for Dysplastic Barrett's Esophagus? Two Year Follow-Up of the AIM-Dysplasia Randomized Sham-Controlled Trial (2009) (2)
Influence of H. pylori infection on meal-stimulated gastric acid secretion and gastroesophageal acid reflux. (1999) (2)
Su1075 Development of a High Resolution Esophageal Manometry (HREM) Training System Identifies Significant Variation in HREM Learning Curves (2016) (2)
Barrett esophagus and esophageal adenocarcinoma (2009) (2)
W1881 In Neoplastic Barrett's Epithelial Cells, Esomeprazole Induces Apoptosis Through the Production of Reactive Oxygen Species: A Potential Role for PPIs in the Chemotherapy of Barrett's Cancer (2010) (2)
Mo1672 Clinical Implications of Endoscopic and Histological Signs of Active Colitis in Patients With Ulcerative Colitis in Clinical Remission (2012) (2)
A Human Barrett's Esophagus Organoid System Reveals Epithelial-Mesenchymal Plasticity Induced by Acid and Bile Salts. (2022) (2)
M1014 For Patients with Colorectal Cancer, the Long-Term Use of Statins Is Associated with Better Clinical Outcomes (2009) (2)
Endoscopic eradication therapy and the test of time. (2018) (2)
In Esophageal Squamous Cell Lines Derived From GERD Patients With and Without Barrett's Esophagus, There Are Differences in NF-κB Activation After Acid and Bile Salt Exposure (2011) (2)
A case of duodenal Entamoeba histolytica. (2009) (2)
Squamous cell carcinoma of the esophagus (2004) (2)
Acid suppression therapy for Barrett's esophagus. (2001) (2)
Timing of Resumption of Anticoagulation After Polypectomy and Frequency of Post-procedural Complications: A Post-hoc Analysis (2022) (2)
SPECIAL REPORTS AND REVIEWS (1996) (2)
American registry of pathology expert opinions: Evaluating patients with eosinophilic esophagitis: Practice points for endoscopists and pathologists. (2019) (2)
Guidelines for managing short-segment Barrett's esophagus. (2000) (2)
896 A PROSPECTIVE, RANDOMIZED TRIAL OF PROPHYLACTIC HEMOCLIPPING FOR PREVENTING DELAYED POST-POLYPECTOMY BLEEDING IN PATIENTS WITH LARGE COLONIC POLYPS (2019) (2)
Risk Stratification for Esophageal Adenocarcinoma Screening and Surveillance. (2006) (2)
883: DOUBLE-BLIND RANDOMIZED TRIAL OF THE POTASSIUM-COMPETITIVE ACID BLOCKER VONOPRAZAN VS. THE PROTON PUMP INHIBITOR LANSOPRAZOLE IN U.S. AND EUROPEAN PATIENTS WITH EROSIVE ESOPHAGITIS (2022) (2)
Is esomeprazole an effective therapy for patients with GERD who have night-time heartburn? (2006) (2)
Cardiac mucosa, Barrett's oesophagus and cancer of the gastro-oesophageal junction: what's in a name? (2016) (1)
444 - Characterization of Conditions Underlying Heartburn Refractory to Proton Pump Inhibitors (PPIS) in a VA Cooperative Study of Medical and Surgical Treatments for PPI-Refractory Heartburn (2018) (1)
543 Support for Wound Healing As the Mechanism for Columnar Metaplasia of the Esophagus in a Rodent Model of Barrett's Esophagus (2015) (1)
CANCER OF THE ESOPHAGUS (1995) (1)
W1052 Post-Polypectomy Bleeding Rates are Not Significantly Increased for Patients Who Take Clopidgorel and Do Not Stop it Prior to Colonoscopy (2010) (1)
Study of Acid-related Disorders: Real-world Physician and Patient Perspectives on Burden of Helicobacter pylori Infection (2022) (1)
Histologic Study of the Esophagogastric Junction of Organ Donors Reveals Novel Glandular Structures in Normal Esophageal and Gastric Mucosae (2021) (1)
M1966 NADPH Oxidase NOX5-S Mediates Cyclin D1 Expression in Barrett's Esophageal Adenocarcinoma Cells (2008) (1)
709 Reduction in LDL Cholesterol Levels During Statin Therapy Is Associated with a Reduced Incidence of Advanced Colon Polyps (2009) (1)
1063 Omeprazole Blocks Secretion of the Inflammatory Cytokine IL-8 in Esophageal Squamous Epithelial Cells Exposed to Acid and Bile Salts: A Potential Anti-Inflammatory Effect of PPIs Independent of Acid Inhibition (2010) (1)
Oesophagus: A new candidate for the progenitor cell of Barrett metaplasia (2018) (1)
Correction: Development, Calibration, and Validation of a U.S. White Male Population-Based Simulation Model of Esophageal Adenocarcinoma (2010) (1)
Incidence of Colorectal Cancer and Extracolonic Cancers in Patients with Inflammatory Bowel Disease: 601 (2016) (1)
Unreliability of the serum amylase determination in the diagnosis of acute alcoholic pancreatitis (1982) (1)
Achieving better outcomes for patients with GERD (1996) (1)
VONOPRAZAN VERSUS LANSOPRAZOLE FOR HEALING AND MAINTENANCE OF HEALING OF EROSIVE ESOPHAGITIS: A RANDOMIZED TRIAL. (2022) (1)
579 Increased Expression, Secretion and Activation of IL-6 During the Neoplastic Progression of Barrett's Esophagus (2009) (1)
Tu1181 The Induction of Acute Reflux Esophagitis in Humans Causes Hypocontractile Esophageal Motility Alterations (2015) (1)
500 The Induction of Pathological Acid Reflux With Acute Reflux Esophagitis in Humans Is Associated With T Lymphocyte-Predominant Inflammation of the Esophageal Mucosa: A New Paradigm for the Pathogenesis of Reflux Esophagitis (2015) (1)
166 – L-Type Calcium Channel Inhibitors (Verapamil and Diltiazem) Block Th2-Cytokine-Stimulated Eotaxin-3 Secretion in Esophageal Squamous Cells from Patients with Eosinophilic Esophagitis (2019) (1)
Acid perfusion activates a proliferative response in the squamous epithelium of patients with erosive esophagitis, but not of patients with Barrett's esophagus (2001) (1)
315 The Risk of Lymph Node Metastases in Patients With High Grade Dysplasia or Intramucosal Carcinoma in Barrett's Esophagus: A Systematic Review (2012) (1)
A Prospective, Case-Control Study of Factors That Trigger Flares of Inflammatory Bowel Disease (2011) (1)
Chapter Fourteen – Barrett's esophagus (2006) (1)
A Prospective, Controlled Study of Post-Polypectomy Bleeding for Patients on Uninterrupted Thienopyridine Therapy During Elective Colonoscopy (2011) (1)
USCAP 2018 Abstracts: Gastrointestinal Pathology (657–893) (2018) (1)
Clarifying misunderstandings and misinterpretations about proton pump inhibitor-responsive oesophageal eosinophilia (2016) (1)
ACG Clinical Guideline: Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease (1)
Sa1827 Barrett's Esophagus Is Not Rare in Asian Patients Who Have Endoscopy With Esophageal Biopsies Taken in the United States (2014) (1)
Spastic secondary contractile patterns identified by FLIP panometry in symptomatic patients with unremarkable high‐resolution manometry (2022) (1)
Gastroesophageal Reflux Disease (GERD) . State of the art (2007) (1)
Medical treatment of Barrett’s esophagus (2000) (1)
657 Prone vs Standard, Left-Lateral Decubitus Position Colonoscopy for Obese Patients: A Randomized, Prospective Study (2012) (1)
Mo1853 Low Prevalence of Eosinophilic Esophagitis in Hispanics and Asians in the United States (2014) (1)
USCAP 2018 Abstracts: Gastrointestinal Pathology (657–893) (2018) (1)
Sa1468 The Peripheral Blood Lymphocyte to Monocyte Ratio Can Predict Mortality in Patients With Pancreatic Adenocarcinoma (2016) (1)
1004 A Prospective, Randomized Trial of Prophylactic Hemoclipping for Preventing Delayed Post-Polypectomy Bleeding in Patients With Large Colonic Polyps: An Interim Analysis (2017) (1)
The Long-Term Use of Statins Is Associated with a Decreased Incidence of Advanced Adenomatous Colon Polyps: 1388 (2008) (1)
Esophageal leiomyomas (2000) (1)
[Pathogenesis and epidemiology of Barrett esophagus]. (1994) (1)
Through-the-Scope, Wire-Guided Esophageal Dilation for the Treatment of Food Impaction (2008) (1)
Evaluation and Management of Patients with PPI-Refractory Heartburn (2021) (0)
37 Ursodeoxycholic Acid Protects Against Deoxycholic Acid-Induced DNA Damage and NF-kB Activation in Barrett's Metaplasia In Vitro and In Vivo (2012) (0)
Su1177 Barrett's Metaplasia Expresses Functional Foxa2, an Endodermal Transcription Factor Involved in Goblet Cell Development (2012) (0)
Mo1215 Ethnic Distribution of Barrett's Metaplasia in the United States Is Inversely Associated With H. pylori Prevalence (2016) (0)
S1418 Treatment Patterns, Goals, Satisfaction, and Adherence in the Management of H. pylori Infection in the United States: Results From the Study of Acid-Related Disorders (SOARD) (2021) (0)
255 Clinical Implications of Histologic Abnormalities in Ileocolonic Biopsy of Crohn's Patients in Clinical Remission (2014) (0)
Su2052 Clinical Features That Predict Survival for Patients With Hepatocellular Carcinoma (2012) (0)
897 Bile Acids Cause DNA Damage in Benign Barrett's Epithelial Cells, Which Resist Apoptosis Through Nf-κB Activation (2008) (0)
Sa175 SUSTAINED ESOPHAGEAL CONTRACTIONS DEMONSTRATED ON FUNCTIONAL LUMEN IMAGING PROBE (FLIP) CORRELATES WITH ESOPHAGEAL SYMPTOM SEVERITY AND HRM FINDINGS (2021) (0)
866 CD252 (OX40L)+ ANTIGEN PRESENTING CELLS ARE PRESENT IN THE ACTIVE EOE ESOPHAGEAL EPITHELIUM (2020) (0)
Discussion. Acid suppression for the long-term management of reflux disease: Part 1 (1992) (0)
S0452 Impact of EndoFLIP in an Esophageal Clinical Practice (2020) (0)
For Patients with Crohnʼs Disease, Biologic Agent Use Varies Inversely with Age at the Time of Diagnosis: 1219 (2009) (0)
860 Development and Characterization of a Surgical, Mouse Model of Reflux Esophagitis and Barrett's Esophagus (2013) (0)
669: IL-13/IL4Rα SIGNALING INCREASES TENSION IN HUMAN CIRCULAR ESOPHAGEAL SMOOTH MUSCLE THROUGH INCREASES IN EXPRESSION AND PHOSPHORYLATION OF CPI-17: POTENTIAL CONTRIBUTION TO REDUCED ESOPHAGEAL DISTENSIBILITY IN EOE (2022) (0)
509 In Barrett's Epithelial Cells, Lipopolysaccharide (LPS) Induces TLR4 Signaling With Activation of the NLRP3 Inflammasome, Pro-Inflammatory Cytokine Secretion and Pyroptosis: A Potential Role for the Esophageal Microbiome in Barrett's Carcinogenesis (2015) (0)
Response to Orel and Turk, and to Moawad et al. (2010) (0)
Sa1886 Esophageal Squamous Cells Exposed Repeatedly to Acid and Bile Salts In Vitro Exhibit Columnar Differentiation With Features of Barrett's Metaplasia (2015) (0)
Discussion. Acid suppression for the long-term management of reflux disease: Part 2 (1992) (0)
Have conventional pH monitoring techniques substantially underestimated the duration of acid exposure for the most distal segment of the oesophagus ? (2003) (0)
Sa1660 - Esophageal Adenocarcinoma (Eac) Exosomes Induce Features of Epithelial Mesenchymal Transition in Non-Neoplastic Barrett's Epithelial Cells: A Potential Mechanism for Carcinogenesis in the Barrett's Metaplasia Surrounding Eacs (2018) (0)
Sa1216: FLIP PANOMETRY FREQUENTLY REVEALS ABNORMAL CONTRACTILE RESPONSE PATTERNS IN OBESE PATIENTS WHO ARE CANDIDATES FOR BARIATRIC SURGERY (2022) (0)
Implications of Recent Revelations from Basic and Clinical Studies of Barrett’s Esophagus for Screening and Surveillance Strategies (2021) (0)
Nutritional Indices as Predictors of Mortality and Metastases in Esophageal Cancer: 454 (2016) (0)
W1124 PPI-Resistant Heartburn in Veteran Patients: Underlying Conditions and Response to Alterations in the Dosage and Type of PPI Prescribed (2010) (0)
Su1972 Differences in Survival Between Patients With Esophageal Adenocarcinoma and Squamous Cell Carcinoma Are Not Due to Differences in Demographic Factors or Tumor Location (2014) (0)
Serum Albumin is an Independent Predictor of Early Mortality in Veteran Patients With Esophageal Cancer: 40 (2014) (0)
Sa1839 Atonal Homolog 1 (ATOH1) Upregulates Gastric-and Intestinal-Type Protein Expression in Esophageal Squamous Cells, and Increases Proliferation in Barrett's Cells: Potential Roles for ATOH1 in Barrett's Pathogenesis and Carcinogenesis (2014) (0)
The NPG Score: A Novel Nutritional and Inflammatory Index for Predicting Mortality in Esophageal Cancer (2017) (0)
Sa1153 - Esophageal Squamous Cells from Eosinophilic Esophagitis Patients Express a Non-Gastric Proton Pump, and their Th2 Cytokine-Stimulated Secretion of Eotaxin-3 can be Blocked by a Potassium-Competitive Acid Blocker and a Histamine H 2 -Receptor Antagonist (2018) (0)
Debate: endoscopy is unnecessary in the management of uncomplicated GERD. (2006) (0)
W1873 Honokiol Exerts Pronounced Anti-Proliferative and Pro-Apoptotic Effects in Transformed Barrett's Epithelial Cells That Have Active RAS and Inactive p53. (2010) (0)
An Implantable Wireless Impedance Sensor Capable of Distinguishing Air, Water and Acid in Gastroesophageal Reflux (2007) (0)
Esophageal Cancer Surveillance and Screening: Barrett's Esophagus and GERD (2004) (0)
Dr. Vincent and Colleagues comment (1985) (0)
155 PRODUCTS OF MATURE ADIPOCYTES IN VISCERAL FAT OF OBESE PATIENTS IMPAIR ESOPHAGEAL EPITHELIAL BARRIER FORMATION AND FUNCTION. (2020) (0)
Mo1169 In Patients With Barrett's Esophagus and in Barrett's Epithelial Cell Lines Ursodeoxycholic Acid Treatment Increases the Expression of Antioxidants (Glutathione Peroxidase 1 and Catalase) and Protects Against Bile Acid-Induced DNA Damage (2013) (0)
544 In Non-Neoplastic Barrett's Epithelial Cells, Acid and Bile Salts Activate VEGF Signaling to Induce Epithelial Mesenchymal Transition Through ZEB2, a Transcriptional Repressor of E-Cadherin (2015) (0)
Su1136 THE GASTRIC CARDIA REVISITED: SURPRISING RESULTS FROM EXAMINATION OF THE ESOPHAGUS AND STOMACH OF ORGAN DONORS (2020) (0)
126 In Barrett's Cancer Cells, Activation of VEGFR2 Increases Cell Proliferation Through a PLC-Dependent Pathway That Can Be Inhibited by Sunitinib (2012) (0)
Acid and bile exposure cause additive MAPK activation and proliferation in a Barrett's adenocarcinoma cell line (2003) (0)
The simple function of the esophagus belies the organ’s complexity. Editorial. (2013) (0)
Products of Mature Adipocytes in Visceral Fat of Obese Patients Impair Esophageal Epithelial Barrier Formation and Function (2020) (0)
Invited response to letter to the editor by Tustumi et al (2021) (0)
T1045 Chronic Diabetic Complications are Associated With an Increased Incidence of Advanced Adenomatous Colon Polyps in a Male Veteran Population (2010) (0)
203 A STAT6 Inhibitor (AS1517499) and a Tyrosine Kinase Inhibitor (Leflunomide) Block IL-13/STAT6 Signaling and Eotaxin-3 Expression in Esophageal Fibroblasts and Epithelial Cells: Promising Agents to Improve Inflammation and Prevent Fibrostenosis in EoE (2015) (0)
Tu1143 Diagnosis of Esophageal Motility Disorders: Esophageal Pressure Topography Versus Conventional Line Tracings (2015) (0)
Mo1227 IN HUMAN ESOPHAGEAL SMOOTH MUSCLE CELLS, IL-4 STIMULATES EOTAXIN-3 SECRETION THAT IS BLOCKED ONLY MINIMALLY BY A PPI OR A P-CAB. (2020) (0)
280 – Inhibitory Smad6 Reduces Sox9 Expression in Esophageal Squamous and Barrett's Epithelial Cells: Potential Role for Canonical Bmp4 Signaling in Barrett's Pathogenesis (2019) (0)
P607. Esophagogastric Fistula Related to Nissen Fundoplication (2014) (0)
Epidemiology of cancer in Barrett’s oesophagus (2009) (0)
Why does alcoholism predispose to alimentary tract cancers (1990) (0)
Gastroesophageal Reflux Disease (GERD) State of the Art Lecture (2016) (0)
Maintenance topical steroid therapy in eosinophilic esophagitis: Not so hard to swallow any more? (2020) (0)
Human Pathophysiology Barrett’s metaplasia develops from cellular reprograming of esophageal squamous epithelium due to gastroesophageal reﬂux (2017) (0)
Su1175 Bone Morphogentic Protein 4 Signaling Alters MicroRNA-145 Expression in the Esophagus (2012) (0)
Subject Index, Vol. 51, Supplement 1, 1992 (1992) (0)
Editorial introductions. (2018) (0)
528 – In Barret's Epithelial Cells, Nucleophosmin 1 Facilitates Repair of Oxidative Dna Damage Caused by Acidic Bile Salts Through P38-Dependent Effects on the Base Excision Repair Pathway (2019) (0)
Sa1884 BMP4 Induces SOX9 and Columnar Cytokeratin Expression in Esophageal Squamous Cells and Increases Proliferation in Barrett's Cells Through the p38MAPK Pathway: Potential Roles for BMP4-p38MAPK Signaling in Barrett's Pathogenesis and Carcinogenesis (2015) (0)
The Effect of Obesity on Esophageal Adenocarcinoma (2011) (0)
Tu1166: IN BARRETT'S EPITHELIAL CELLS, APE1/REF-1 IS REQUIRED FOR ACIDIC BILE SALT-INDUCED VEGF EXPRESSION: A POTENTIAL MECHANISM FOR DEVELOPMENT OF SUB-SQUAMOUS INTESTINAL METAPLASIA IN BARRETT'S ESOPHAGUS (2022) (0)
IL‐13/IL4Rα Signaling Increases Tension in Human Circular and Longitudinal Esophageal Smooth Muscle Through Distinct Molecular Pathways: Potential Contribution to Reduced Esophageal Distensibility in EoE (2021) (0)
In Esophageal Fibroblasts, TH2 Cytokines Induce Pro-Fibrotic Periostin Expression that can be Blocked by JAK-STAT6 Inhibitors (2017) (0)
643 In Esophageal Epithelium, the Transcription Factor FOXA2 is a Hedgehog Target Gene That May Mediate Columnar Metaplasia, as Occurs in Barrett's Esophagus (2012) (0)
Tu1123 Acid and Bile Salts Activate Hypoxia Inducible Factor (HIF)-2α and Increase Transcription of HIF-Target PRO-Inflammatory Cytokines in Esophageal Squamous Cell Lines: A Potential Mechanism for the Pathogenesis of Reflux Esophagitis (2012) (0)
599 in Esophageal Squamous Epithelial Cells From Patients With EoE, Omeprazole Blocks Cytokine-Stimulated Eotaxin-3 Secretion by Reducing Binding of STAT6 to the Eotaxin-3 Promoter. (2012) (0)
W1888 A New Technique of Through-the-Scope, Wire-Guided Esophageal Dilation for the Treatment of Esophageal Food Impaction (2008) (0)
332 - Reflux-Induced Epithelial Mesenchymal Transition: A Potential Mechanism for the Development of Sub-Squamous Intestinal Metaplasia in Barrett's Esophagus (2018) (0)
Sa1291 Clinical Features of Los Angeles (LA) Grade D Esophagitis Differ Significantly from LA Grade A Esophagitis: Evidence that Factors other than GERD Contribute to the Development of LA Grade D Esophagitis (2016) (0)
S0356 A Tertiary Esophageal Center’s Experience With EsoFLIP (2020) (0)
Reviewer Recognition 2006 (2007) (0)
138 LDN-193189, a BMP Type I Receptor Inhibitor, Reduces SMAD and p38MAPK Signaling and SOX9 Expression in Barrett's Epithelial Cells: Potential Role for Canonical and Non-Canonical BMP4 Signaling in Barrett's Pathogenesis (2016) (0)
505 SURPRISING LACK OF CORRELATION BETWEEN INTEGRATED RELAXATION PRESSURE LEVEL AND SYMPTOM SEVERITY IN PATIENTS WITH ACHALASIA (2020) (0)
M1819 Exposure to Acid and Bile Salts Causes Esophageal Squamous Cells to Secrete Chemokines That Stimulate Immune Cell Migration (2009) (0)
Endoscopic Evaluation of the Esophagus and Endoscopic Ultrasonography of the Esophagus (2019) (0)
Heartbur inpatients withachalasia (1995) (0)
Barrett's esophagus: Definition and diagnosis (2015) (0)
Mo1935 Exposure to Acid and Bile Salts Induces Features of Epithelial Mesenchymal Transition in Non-Neoplastic Barrett's Epithelial Cells: A Potential Mechanism for Reflux-Induced Remodeling and Carcinogenesis in Barrett's Esophagus (2013) (0)
248 Differences in CDX-2 Expression After Exposure to Acid and Bile Salts in Esophageal Squamous Cell Lines Derived from GERD Patients with and Without Barrett's Esophagus (2009) (0)
What is the long-term effect of high-dose versus standard-dose omeprazole in patients with dyspepsia? (2004) (0)
Su1054 - in Barrett's Epithelial Cells, Ursodeoxycholic Acid Hastens Repair of Oxidative DNA Damage Caused by Acidic Bile Salts Through P38-Dependent Effects on the Base Excision Repair (2018) (0)
Comparison of Endoscopic Stenting Versus Surgical Jejunostomy Tube for Maintainance of Nutrition and Dysphagia in Patients with a Malignant Esophageal Stricture Receiving Neoadjuvant Chemoradiation (2008) (0)
167 – Eoe Esophageal Epithelial Cells Induce Th2 Polarizing Dendritic Cells (2019) (0)
Discussion Practical Considerations Regarding Long-Term Treatment with Omeprazole (2004) (0)
Decreasing Rates of Gastrointestinal Cancer at a Veterans Affairs Hospital Between 1994 to 2013: 1000 (2016) (0)
S1069 Differences Between Esophageal Squamous Cells From Patients With GERD and Eosinophilic Esophagitis in the Stimulated Secretion of Eotaxin-3: A Mechanism That Might Underlie Differences Between the Disorders in the Type of Esophageal Inflammation. (2010) (0)
UTILITY OF BOTULINUM TOXIN INJECTION OF THE LOWER ESOPHAGEAL SPHINCTER FOR IDENTIFYING ACHALASIA-VARIANT CASES OF ESOPHAGOGASTRIC JUNCTION OUTFLOW OBSTRUCTION (2022) (0)
Medical versus Surgical Treatment for Refractory Heartburn. Reply. (2020) (0)
S0357 Differences in Clinical Features and Treatment Outcomes Between Patients With Dysphagia-Predominant and Chest Pain-Predominant Esophagogastric Junction Outflow Obstruction (EGJOO) (2020) (0)
622 Pathological Acid Reflux Stimulates Esophageal Epithelial Production of Hypoxia Inducible Factor (HIF)-2a and Its Target Pro-Inflammatory Molecules: A Role for HIFs in GERD Pathogenesis (2016) (0)
Barrett's esophagus. (1994) (0)
1082 A PROSPECTIVE ENDOSCOPIC AND HISTOLOGIC STUDY OF ESOPHAGEAL HEALING AFTER RADIOFREQUENCY ABLATION (RFA) OF BARRETT'S ESOPHAGUS (BE) (2020) (0)
993 in Esophageal Squamous Cell Lines, Acidic Bile Salts Induce Reactive Oxygen Species That Increase Hypoxia Inducible Factor (HIF)-2a Levels Through Post-Translational Regulation: A Potential Pathogenetic Mechanism for Reflux Esophagitis (2013) (0)
410 LES MUSCLE OF PATIENTS WITH ACHALASIA EXHIBITS STRIKING QUANTITIES OF MAST CELL DEGRANULATION PRODUCTS IN PERIMYSIUM AND AROUND NERVES (2020) (0)
Adenocarcinoma Cells and Induces Apoptosis in Human Esophageal Selective Inhibition of Cyclooxygenase-2 Suppresses Growth Updated (2000) (0)
Discussion Acid-Related Diseases – New Perspectives (1992) (0)
The Development of Quality Measures for the Performance and Interpretation of Esophageal Manometry (2016) (0)
352. ENDOSCOPIC SCORING SYSTEM FOR ACHALASIA PRE AND POST LOWER ESOPHAGEAL SPHINCTER INTERVENTION: THE DELAYED ESOPHAGEAL CLEARANCE IN ACHALASIA (DECA) SCORE (2022) (0)
What's New in GI Pharmacology Course Pennsylvania Convention Center Philadelphia, Pennsylvania (2007) (0)
387 Tumor Cells in Human Esophageal Adenocarcinomas Exhibit Active VEGF/VEGFR2 Signaling and, in Mice Bearing Xenografts of Transformed Barrett's Cells, Sunitinib (A VEGFR2 Inhibitor) Blocks Tumor Growth in an Angiogenesis-Independent Fashion (2013) (0)
Acid activation of the p38 mitogen-activated protein kinase pathway induces transcription of cyclooxygenase-2 in human Barrett's-associated adenocarcinoma cells (2003) (0)
S374 Patient Burden and Treatment Goals in the Management of Erosive Esophagitis in the United States: Results From the Study of Acid-Related Disorders (SOARD) (2021) (0)
AJG-22-1057 1583..1592 (0)
How to Build the Trust of Your Referring Physicians (2016) (0)
1080: ESOPHAGOGASTRIC JUNCTION FAT PAD TISSUE FROM OBESE PATIENTS CAUSES ESOPHAGEAL SQUAMOUS CELLS TO ALTER THEIR TRANSCRIPTION OF GENES INVOLVED IN CELL-CELL ADHESION. (2022) (0)
PPls May Not Predispose to Eosinophilic Esophagitis. Authors' reply (2010) (0)
528 The Rate of Post-Polypectomy Bleeding for Patients on Uninterrupted Clopidogrel Therapy During Elective Colonoscopy Is Acceptably Low (2011) (0)
Honokiol Exerts PRO-Apoptotic Effects in Transformed Barrett's Epithelial Cells Through Inhibition of the STAT3 Pathway. (2011) (0)
Su1126 Omeprazole Blocksth2-Cytokine-Stimulated Secretion of Eotaxin-3 in Esophageal Squamous Cells From Patients With EoE and From Patients With GERD (2012) (0)
Barrett's esophagus: Weighing the risks (2002) (0)
333 - Differential Effects of PPI Therapy on Hedgehog Pathway, SOX9, and P63 Gene Expression in Squamous Epithelial Biopsies from Gerd Patients with or without Barrett's Esophagus: Implications for Reversibility of Esophageal Epithelial Molecular Reprogramming (2018) (0)
Mo1933 FOXJ1, a Hedgehog Pathway Target Gene, Downregulates the Expression of Squamous Cell Transcription Factors in Esophageal Squamous Epithelial Cells and Is Highly Expressed in Barrett's Epithelial Cells (2013) (0)
Sa174 A NOVEL INTEGRATED APPROACH TO DESCRIBE PATIENTS ALONG A SPECTRUM OF ESOPHAGEAL DYSMOTILITY (2021) (0)
931 Non-Neoplastic, Barrett's Epithelial Cells That Express Oncogenic RAS Can Be Transformed Through Forced Expression of Constitutively Active STAT3. (2014) (0)
331 - Disparate Effects of BMP4 Signaling in Esophageal Squamous Cells and Barrett's Epithelial Cells Might Contribute to the Pathogenesis of Barrett's Esophagus (2018) (0)
Barium Enema Examinations v Endoscopy-Reply (1982) (0)
Mo1724 POST-POLYPECTOMY BLEEDING RATES ARE SIMILIAR IN PATIENTS WHOSE ANTICOAGULATION IS RESUMED EARLY OR LATER AFTER POLYPECTOMY, BUT THE INCIDENCE OF THROMBOEMBOLIC EVENTS IS HIGHER IN THE LATE RESUMPTION GROUP: POST-HOC ANALYSIS OF A PROSPECTIVE TRIAL (2020) (0)
542 Malignant Transformation of Non-Neoplastic Barrett's Epithelial Cells Through Well-Defined Genetic Manipulations (2009) (0)
Products of GEJ Fat of Obese Patients Cause Rapid and Reversible Impairment of Esophageal Epithelial Barrier Function (2021) (0)
S383 Proposed Endoscopic Scoring System for Achalasia: The Delayed Esophageal Clearance in Achalasia (DECA) Score (2021) (0)
AJG-21-1549 2357..2366 (0)
Sa135 BIOPSY-DERIVED HUMAN BARRETT'S ESOPHAGUS ORGANOIDS EXPRESS PHENOTYPIC MARKERS OF COLUMNAR, INTESTINAL, AND ESOPHAGEAL SUBMUCOSAL GLAND CELLS (2021) (0)
174 Expression of Oncogenic H-RASG12v Does Not Induce Malignant Transformation or Senescence in Barrett's Epithelial Cells (2008) (0)
Therapeutic approaches to reflux disease: newer approaches and strategies to columnar-lined esophagus. (2003) (0)
T1925 The Prevalence of Barrett's Esophagus in the US: Estimate Confirmation Using a Simulation Model and SEER Data (2009) (0)
Sa1842 In Esophageal Epithelial Cells From Barrett's Patients, Protein Kinase a Phosphorylates SOX9, Enhancing Its Binding to Target Gene Promoters: A Potential Role for SOX9 in Barrett's Pathogenesis (2014) (0)
In Non-Neoplastic Barrett's Epithelial Cells, Acid and Bile Salts Induce Epithelial Mesenchymal Transition (EMT) through a Hif-Mediated Reduction in Microrna-200a and -200b Expression (2017) (0)
Relationship of Eosinophilic Esophagitis to Gastroesophageal Reflux (2012) (0)
Sa1885 ΔNp63 Upregulates Expression of Squamous Cytokeratins and Increases Proliferation in Squamous Cells, but Decreases Proliferation in Barrett's Cells: A Potential Role for Downregulation of ΔNp63 in Barrett's Pathogenesis (2015) (0)
development of oesophageal adenocarcinoma Role of a novel bile acid receptor TGR 5 in the (0)
499 SUSTAINED ESOPHAGEAL CONTRACTIONS (SEC) BY FLIP PROVIDES ADDITIONAL CHARACTERISTICS ON ESOPHAGEAL DYSMOTILITY IN PATIENTS WITH ESOPHAGEAL SYMPTOMS (2020) (0)
W1186 A Portable Wireless System for Integrated Batteryless Impedance- And pH-Sensor Implants to Detect GERD Episodes (2010) (0)
Tu2065 In Rats After Esophagojejunostomy, Reflux Esophagitis is Accompanied by the Expression of SOX-9 in Basal Cells of the Squamous Epithelium and in Barrett's Metaplasia (2012) (0)
Tu1875 Cross-Talk Between HIF-2α and NF-κB Mediates Pro-Inflammatory Cytokine Expression by Esophageal Squamous Cells Exposed to Acid and Bile Salts (2014) (0)
Interrater Reliability of Functional Lumen Imaging Probe (FLIP) Panometry and High-Resolution Manometry for Assessment of Esophageal Motility Disorders. (2023) (0)
Subepithelial Fibrosis is a Distinctive Characteristic of Eosinophilic Esophagitis: 57 (2014) (0)
Utility of CA 19-9 in Predicting Metastatic Pancreatic Adenocarcinoma in Veteran Patients: 19 (2015) (0)
Tu1127 - The Risk of Neoplastic Progression Associated with Aberrant Immunostaining for P53 in Barrett's Esophagus: Systematic Review and Meta-Analysis (2018) (0)
990 Nitric Oxide Profoundly Decreases Sox-2 Expression and AKT Signaling in Esophageal Squamous Cells: A Potential Mechanism Underlying Barrett's Metaplasia (2013) (0)
Mo1214 Eotaxin-3 Expression by Esophageal Epithelial Cells Correlates Inversely With Acid Reflux in Patients With Symptomatic Esophageal Eosinophilia (2016) (0)
52. Barrett Esophagus and Esophageal Adenocarcinoma (2015) (0)
Su1231: FREQUENT DISCREPANCIES AMONG DIAGNOSTIC TESTS FOR DETECTING LOWER ESOPHAGEAL SPHINCTER-RELATED ESOPHAGEAL OBSTRUCTION (2022) (0)
Editorial introductions. (2016) (0)
RUNNING TITLE: Beta-defensins in EoE (2013) (0)
Response to Haseeb et al. (2022) (0)
Patient journey in erosive oesophagitis: real-world perspectives from US physicians and patients (2022) (0)
Multiple rings of the esophagus: A consequence of chronic esophagitis? (1997) (0)
930 Acid and Bile Salts Induce Features of Epithelial Mesenchymal Transition in Non-Neoplastic Barrett's Epithelial Cells Through Increased VEGFSignaling (2014) (0)
Incidental Goblet Cells at the Gastroesophageal Junction: Intestinal Metaplasia of the Esophagus or Stomach?: 464 (2016) (0)
Nanofabricated Sensing Electrodes in a Batteryless Endoluminal Sensing Telemeter for Diagnosis of Gastroesophageal Reflux Disease (GERD) (2010) (0)
P1. A Single Paraffin-Embedded or RNA-Later-Preserved Esophageal Biopsy Is Valid for Genetic Diagnosis of Eosinophilic Esophagitis Regardless of Location in the Esophagus (2014) (0)
Management Options for Patients With Proven GERD and Persistent Symptoms on Proton Pump Inhibitors: 415 (2017) (0)
Barrett's esophagus. (1999) (0)
Acid exposure causes intracellular acidification and proliferation in a Barretts adenocarcinoma cell line (2002) (0)
S0449 A Genetic “Mototype” of LES Muscle Distinguishes Among Manometric Phenotypes in Patients With Achalasia Associated With Mast Cell Degranulation (2020) (0)
Mo1179 In Children With Esophageal Eosinophilia, Most Esophageal Biopsies Contain Insufficient Lamina Propria to Evaluate for Fibrosis, and Fibrosis often Is Present When Endoscopy Shows Only an Inflammatory Phenotype (2016) (0)
34 Reflux Esophagitis May Result Primarily from An Immune-Mediated Injury Rather Than from a Caustic, Chemical Injury (2009) (0)
W1966 Unlike Deoxycholic Acid, Ursodeoxycholic Acid Does Not Cause DNA Damage or Activate the NF-κB Pathway in Barrett's Metaplasia In Vitro and In Vivo (2009) (0)
The broad impact of functional lumen imaging probe panometry in addition to high-resolution manometry in an esophageal clinical practice. (2022) (0)
Esophageal and Gastroesophageal Junction Adenocarcinoma (2007) (0)
SOX2 and Î"NP63 Increase Squamous Cytokeratin Expression and Proliferation in Esophageal Squamous Cells, but Decrease Proliferation in Barrett’s Cells: A Potential Role for SOX2 and Î"NP63 Downregulation in Barrett’s Pathogenesis (2017) (0)
Sa1253 Use of Gastric Acid Suppressing Drugs and Subsequent Risk of Celiac Disease; A Population-Based, Case-Control Study (2013) (0)
Point-Counterpoint: Why Has Screening and Surveillance for Barrett's Esophagus Fallen Short in Stemming the Rising Incidence of Esophageal Adenocarcinoma? (2022) (0)
Epithelial-Mesenchymal Transition in Barrett's Esophagus: The Role of HIF-1α, microRNA-200, SP1, and MAZ (2017) (0)
Editorial introductions. (2017) (0)
Tu1952 Survival Analysis of Veteran Patients With Resectable Pancreatic Tumors With and Without Surgery (2015) (0)
Gastroesophageal Junction Fat Pad Tissue from Obese Patients Impairs Esophageal Epithelial Barrier Function and Disrupts Cell‐to‐Cell Connections (2021) (0)
How can the incidence of carcinoma in Barretts esophagus be satisfactorily assessed? What are the shortcomings of the different incidence studies? (1994) (0)
Granulomatous Esophagitis: Crohnʼs Disease in Rare Form (2018) (0)
Duration of the Interval Between Completion of the Bowel Preparation and Start of the Colonoscopy As a Better Predictor of Bowel Preparation Quality Than Colonoscopy Start Time Alone (2008) (0)
430 Different Effects of Proton Pump Inhibitors (PPIs) on Eotaxin-3 Protein Expression by the Proximal and Distal Esophagus of Children With Esophageal Eosinophilia (2014) (0)
VALIDATION OF A NOVEL INTEGRATED APPROACH TO DESCRIBE PATIENTS ALONG A SPECTRUM OF ESOPHAGEAL DYSMOTILITY (2022) (0)
69 Ruxolitinib, a Selective JAK1/2 Inhibitor, Blocks IL-13/STAT6 Signaling and Eotaxin-3 Expression in Esophageal Epithelial Cells and Fibroblasts: A Potential Agent to Treat Inflammation and Fibrosis in EoE (2016) (0)
A Comparison of the Rates of Gastrointestinal Bleeding and Mortality in Cirrhotic Patients with Coronary Artery Disease Treated with Cardiac Stents vs Medical Management: 753 (2016) (0)
AGA American Gastroenterological Association Medical Position Statement on the Management of Barrett ’ s Esophagus (0)
909 In Barrett's Epithelial Cells, Ursodeoxycholic Acid Activates p38 and Hastens Repair of DNA Damage Caused by Acidic Bile Salts (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Stuart Jon Spechler?

Stuart Jon Spechler is affiliated with the following schools:

University of California, Berkeley
Stanford University
Baylor University
Massachusetts General Hospital
University of Texas Southwestern Medical Center